Work

Correction: Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

Year: 2009

Type: erratum

Abstract: It has been brought to our attention that Figure 2b in our recently published paper [1] contains an error.Specifically, we inadvertently entered -6.4 rather than +6.4 for the Nadaskevich paper [2] reported in Figure 2b.Recalculation of the summary estimate for diffusing lung capacity of carbon monoxide (DLCO) in this figure revealed a summary mean difference of 3.74, with 95% confidence interval (0.09 to 7.40).This effect is now statistically significant, although the overall conclusion of our meta-analysis, that cyclophosphamide treatment did not result in clinically significant improvement of pulmonary function, is unchanged by this recalculation, as the improvement remains less than the predefined criterion of 10%.The corrected figure 2b is given here as Figure 1.

Source: Arthritis Research & Therapy

DOI: 10.1186/ar2679

Authors: Carlotta Nannini, Colin P West, Patricia J Erwin, Eric L Matteson

Institution: Mayo Clinic

Language: English

Topic: Systemic Sclerosis and Related Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,690

OpenAlex ID: W2602024480

Cites: 2

Cited by: 1

Related to: 10